ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 121 filers reported holding ANAPTYSBIO INC in Q4 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,569,000 | -68.0% | 150,000 | -50.0% | 0.35% | -54.6% |
| Q3 2018 | $29,931,000 | +110.7% | 300,000 | +50.0% | 0.78% | +157.9% |
| Q2 2018 | $14,208,000 | -28.2% | 200,000 | +5.3% | 0.30% | +22.3% |
| Q1 2018 | $19,775,000 | +30.9% | 190,000 | +26.7% | 0.25% | +8.3% |
| Q4 2017 | $15,108,000 | +188.2% | 150,000 | 0.0% | 0.23% | +153.3% |
| Q3 2017 | $5,243,000 | -12.4% | 150,000 | -40.0% | 0.09% | -14.3% |
| Q2 2017 | $5,983,000 | +382.5% | 250,000 | +459.4% | 0.10% | +275.0% |
| Q1 2017 | $1,240,000 | – | 44,690 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |